Merit Medical Systems Inc. logo

Merit Medical Systems Inc.

MMSI | NASDAQ
Chart Builder DCF Calculator
$86.24
-$7.15 (-7.66%)
At close: Oct 30, 2026, 4:00 PM ET
$86.24
$0.00 (0.00%)
After-hours: Oct 30, 2026, 7:30 PM ET

Market Data

Market Cap
$5.15B
Enterprise Value
$5.47B
Beta
0.51
Average Volume
801.98K
Shares Outstanding (Diluted)
60.38M
Shares Change YoY
0.77%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US5898891040

Price Performance

Price Change 1M
0.0%
Price Change 3M
1.4%
Price Change 6M
39.1%
Price Change YTD
-2.2%
Price Change 1Y
-1.5%
Price Change 3Y
25.5%
Price Change 5Y
28.2%
1M CAGR (ann.)
1.0%
1Y CAGR (ann.)
6.0%
5Y CAGR (ann.)
3.6%
All-Time CAGR
14.7%

Valuation

PE Ratio
32.42
Forward PE
17.94
PEG Ratio
0.95
Forward PEG
2.15
PS Ratio
3.20
Forward PS
3.00
PB Ratio
2.95
P/FCF Ratio
25.21
P/Adj. FCF Ratio
32.42
P/OCF Ratio
18.83
EV/Sales
3.39
EV/EBIT
22.41
EV/EBITDA
14.48
EV/FCF
26.77
Earnings Yield
3.1%
FCF Yield
4.0%
Adj. FCF Yield
3.1%

Financial Health

Net Debt
$233.85M
Total Debt
$822.06M
Cash & Short-Term Investments
$503.55M
Total Assets
$2.92B
Current Ratio
4.52
Quick Ratio
3.05
Debt / Equity Ratio
0.47
Debt / EBITDA
2.18
Debt / FCF
4.02
OCF / Debt
0.33
Interest Coverage
6.72
Altman Z-Score
4.29
Piotroski F-Score
7

Margins & Profitability

Gross Profit Margin
49.4%
Operating Profit Margin
13.5%
EBITDA Margin
23.4%
Net Profit Margin
9.9%
FCF Margin
12.7%
Adj. FCF Margin
9.9%
SBC / Revenue
2.8%
SBC Impact (per share)
-22.2%

Returns

Return on Assets
5.5%
Return on Equity
9.7%
Return on Invested Capital
6.2%
Return on Capital Employed
8.2%
Return on Tangible Assets
8.9%

Historical Growth (CAGR)

Revenue CAGR 3Y
9.5%
Revenue CAGR 5Y
8.8%
Revenue CAGR 10Y
10.7%
EPS CAGR 3Y
15.4%
EPS CAGR 5Y
28.5%
EPS CAGR 10Y
20.3%
FCF CAGR 3Y
41.9%
FCF CAGR 5Y
14.1%
FCF CAGR 10Y
37.1%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
8
EPS Growth Next 3Y
24.3%
Revenue Growth Next 3Y
6.6%
Earnings Date
Feb 23, 2027
EPS Estimate (next Q)
$1.12
EPS Growth Est (next Q)
7.7%
Revenue Est (next Q)
$422.77M
Revenue Growth Est (next Q)
7.3%

Fair Value Estimates

Graham Number
$41.78
Graham Upside
-51.5%
Lynch Fair Value
$66.50
Lynch Upside
-22.9%
Price Target
$107.33
Price Target Upside
24.5%

Cash Flow

Operating Cash Flow
$273.74M
Free Cash Flow
$204.24M
Adj. Free Cash Flow
$158.85M
FCF Per Share
$3.42
OCF Per Share
$4.58
OCF/S Ratio
17.0%

Income Statement

Revenue
$1.61B
Gross Profit
$796.04M
Operating Income
$217.37M
EBITDA
$377.54M
Net Income
$160.12M
EPS (Diluted)
$2.66
Revenue / Employee
$214.82K
Profit / Employee
$21.35K
Employees
7,500

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.